|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
10/6/23 Horizon Therapeutics plc 8-K:1,2,3,5 10/6/23 11:611K Donnelley … Solutions/FA
8/8/23 Horizon Therapeutics plc 8-K:2,7,9 8/8/23 12:5.4M Donnelley … Solutions/FA
5/3/23 Horizon Therapeutics plc 8-K:2,9 5/3/23 11:448K Donnelley … Solutions/FA
3/1/23 Horizon Therapeutics plc 8-K:2,9 3/1/23 11:705K Donnelley … Solutions/FA
12/12/22 Horizon Therapeutics plc 8-K:1,5,7,912/10/22 17:2M Donnelley … Solutions/FA
11/29/22 Horizon Therapeutics plc 8-K:7,9 11/29/22 11:169K Donnelley … Solutions/FA
11/2/22 Horizon Therapeutics plc 8-K:2,9 11/2/22 11:778K Donnelley … Solutions/FA
8/3/22 Horizon Therapeutics plc 8-K:2,9 8/3/22 11:728K Donnelley … Solutions/FA
5/4/22 Horizon Therapeutics plc 8-K:2,5,9 4/28/22 11:522K Donnelley … Solutions/FA
5/2/22‡ Horizon Therapeutics plc 8-K:5,9 4/28/22 11:603K Donnelley … Solutions/FA
3/1/22 Horizon Therapeutics plc 8-K:2,9 3/1/22 11:794K Donnelley … Solutions/FA
1/10/22 Horizon Therapeutics plc 8-K:2,9 1/10/22 11:12M Donnelley … Solutions/FA
11/3/21 Horizon Therapeutics plc 8-K:2,5,9 11/3/21 12:819K Donnelley … Solutions/FA
8/4/21 Horizon Therapeutics plc 8-K:2,9 8/4/21 11:769K Donnelley … Solutions/FA
5/5/21 Horizon Therapeutics plc 8-K:2,5,9 5/5/21 11:536K Donnelley … Solutions/FA
4/30/21 Horizon Therapeutics plc 8-K:5,9 4/29/21 11:531K Donnelley … Solutions/FA
3/15/21 Horizon Therapeutics plc 8-K:1,8,9 3/15/21 11:1.7M Donnelley … Solutions/FA
2/24/21 Horizon Therapeutics plc 8-K:2,9 2/24/21 11:782K Donnelley … Solutions/FA
2/1/21 Horizon Therapeutics plc 8-K:1,7,9 1/31/21 15:12M Donnelley … Solutions/FA
1/11/21 Horizon Therapeutics plc 8-K:2,9 1/11/21 11:192K Donnelley … Solutions/FA
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Type: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. |
|